Loading clinical trials...
Loading clinical trials...
Long Term Follow-Up and Collection of Historical Control Data on Menkes Disease Patients
Conditions
Interventions
Long Term Follow-Up
Locations
1
United States
Sentynl Therapeutics
Solana Beach, California, United States
Start Date
December 1, 2019
Primary Completion Date
February 26, 2026
Completion Date
August 31, 2026
Last Updated
March 2, 2026
Lead Sponsor
Sentynl Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions